logo

Exhibiting at VIV Asia 2025

3-4916
Bangkok
12 Mar - 14 Mar, 2025

Product Offerings

Products:

Veterinary Pharmaceuticals: Injectable solutions, oral liquids, powders, tablets, boluses

Samyang Anipharm Co., Ltd., headquartered in Seoul, South Korea, is a renowned manufacturer and exporter specializing in the development, production, and distribution of veterinary pharmaceuticals. The company is a subsidiary of the Samyang Group, which has diversified business operations in various industries, including food, chemicals, pharmaceuticals, and animal health. Samyang Anipharm focuses on providing innovative and effective solutions to meet the needs of the animal health industry.

Core Business

Samyang Anipharm Co., Ltd. is primarily engaged in the manufacture and distribution of veterinary pharmaceuticals, including injectable solutions, oral liquids, powders, tablets, and boluses. Its products are designed to improve animal health, productivity, and welfare. The company leverages cutting-edge technology and rigorous quality control systems to ensure consistent product quality and efficacy.

Product and Service Offerings

Samyang Anipharm offers a comprehensive range of veterinary pharmaceutical products categorized into the following segments:

  1. Injectable Solutions

    • Various injectable formulations designed to treat bacterial, viral, and parasitic infections.
    • High-quality, fast-acting formulations aimed at enhancing animal health and recovery.
    • Applications: Livestock, poultry, and companion animals.
  2. Oral Liquids

    • Nutritional supplements, antibiotics, and vitamins formulated as liquid preparations.
    • Effective in improving growth, immunity, and overall health of animals.
    • Applications: Oral administration for livestock, poultry, and pets.
  3. Powders

    • Antibiotic and nutritional powder formulations aimed at enhancing productivity and disease resistance.
    • Applications: Feed additives for cattle, poultry, swine, and aquaculture.
  4. Tablets and Boluses

    • Specialized formulations designed for easy administration and targeted delivery.
    • Effective treatments for parasitic infestations, bacterial infections, and nutritional deficiencies.
    • Applications: Livestock and companion animals.

Specialization and Core USP

Samyang Anipharm Co., Ltd.’s unique selling proposition lies in its commitment to quality and innovation. The company’s manufacturing processes adhere to Good Manufacturing Practices (GMP), ensuring consistent product quality and safety. Additionally, the company’s expertise in injectable solutions and oral medications makes it a preferred choice for veterinarians and animal health professionals.

Financials

Although specific revenue figures are not publicly disclosed, Samyang Anipharm is known for its strong market presence across South Korea and international markets. Its revenue is primarily driven by the sale of veterinary pharmaceuticals, particularly injectable solutions and oral antibiotics.

Shipments Data

Samyang Anipharm exports its products to various countries across Asia, the Middle East, Africa, and South America. The company's robust supply chain network ensures timely delivery and reliable customer support.

Target Market

Samyang Anipharm serves a diverse range of clients, including:

  • Veterinarians.
  • Livestock Farmers.
  • Poultry Producers.
  • Aquaculture Businesses.
  • Distributors of Veterinary Medicines.

Capabilities

Samyang Anipharm Co., Ltd. operates state-of-the-art manufacturing facilities that comply with GMP (Good Manufacturing Practices). The company’s research and development team is dedicated to developing new products that address emerging challenges in animal health. Its quality assurance systems ensure that all products meet stringent international standards.

Certifications and Compliance Records

Samyang Anipharm maintains compliance with various international standards, including:

  • GMP (Good Manufacturing Practices).
  • ISO 9001:2015 (Quality Management Systems).
  • The company also adheres to stringent regulatory requirements for manufacturing and distributing veterinary pharmaceuticals.

Customer Testimonials

Samyang Anipharm’s clients frequently commend the company for its high-quality products, reliable supply chain, and innovative solutions. Positive feedback highlights the efficacy of its injectable solutions and oral antibiotics in promoting animal health and enhancing productivity.

Major Achievements

  • Successful expansion of its distribution network across Asia, the Middle East, Africa, and South America.
  • Continuous innovation in the development of injectable solutions and oral medications.
  • Recognition as a leading provider of veterinary pharmaceuticals in South Korea and international markets.
  • Implementation of rigorous quality control systems ensuring product safety and efficacy.

Samyang Anipharm Co., Ltd. continues to enhance its reputation as a trusted manufacturer of veterinary pharmaceuticals, delivering innovative solutions designed to meet the evolving needs of the global animal health industry.